Hip Flexor Muscle Activation During Common Rehabilitation and Strength Exercises
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Identification and Search Strategy
2.2. Eligibility Criteria
2.3. Study Selection
2.4. Data Extraction
2.5. Summary Measures and Synthesis of Results
2.6. Risk of Bias Assessment
3. Results
3.1. Study Selection and Characteristics
3.2. Risk of Bias Assessment
3.3. Summary Measures and Synthesis of Results
4. Discussion
4.1. Risk of Bias
4.2. Comparison to Other Systematic Reviews
4.3. EMG Clinical Utility and Application
- Volume Conduction and Motion Artifact: When using skin electrodes, all electrical signals below 400 Hz coming to the skin will be included. All frequencies above 400 Hz are not seen in the EMG signal; therefore, no fast glycolytic motor unit activity will be recorded. It is also impossible to identify the specific muscle(s) of origin (or separate out-motion electrical artifacts). As for the intramuscular electrodes, if the default low-cut filter is 20 Hz, even these will record contaminating cross-talk/volume conduction as muscle EMG. There should be some evidence of selecting a higher low-cut filter and/or repeating analysis with more selective filters to determine if the EMG conclusions would be improved.
- Electrode Placement: The exact location of the placement of the electrodes influences the readings. If you are in the part of the muscle with a high concentration of motor units, the recording will reflect this. However, if the electrodes are placed, for example, near a fascial plane, the recording will not be as good. Depth also matters! Fast glycolytic muscle fibers tend to be more superficial, and slow oxidative fibers are deeper, so knowing the depth you are placing the electrode at is important. Furthermore, if the electrodes are taken out an any point, it will be impossible to re-create the same values, as the electrodes will never be in the exact same positioning.
- Timing of Sample: The importance of beginning the recording of the sample prior to the subject even beginning the desired movement cannot be understated. This is because, often, the peak EMG happens so quickly (within milliseconds) that if the reading is taken too late, the peak value may actually be missed. It is also vital to begin the reading prior to movement in order to record the actual change in activation from the muscle at rest to the muscle in movement.
- Heterogeneity in EMG Methodology: There are large inconsistencies from one study to the next whether we use the bandpass filter, intramuscular versus skin electrodes, reported outcome measurements in %MVIC, amplitude, or RMS of the EMG, electrode placement, and the timing of the sampling. This causes difficulty in comparing the studies and creates a need for extra scrutiny when evaluating the conclusion of each study.
- Lack of Signal Normalization: Normalization of the EMG relying on an individual’s maximum effort on the day of testing is vital to compare values between subjects.
- Erroneous EMG Extrapolations to Muscle Force: EMG does not predict muscle force production. Essentially, when there is change in velocity within a movement, there is no linear relationship between EMG and force output.
4.4. Clinical Exercise Progression
4.5. Limitations
5. Conclusions
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
Appendix A. Additional Search Strategies
Appendix B. Iliopsoas Strengthening Progression
Phase | Level | Weight Bearing Status | Movement | Exercise | Parameters |
---|---|---|---|---|---|
Activation—Stability Focused | 1 | Non-Weight-Bearing | Static | Sitting with a straight back | 5 × 45 s 3×/Day 7 Days/Week 1 Week |
Sitting in hyperlordosis | |||||
2 | Non-Weight-Bearing | Dynamic | Side-lying traditional clam shell | 3 × 10 each side 1×/Day 1 Week | |
Dynamic | Side-lying hip abduction | ||||
Static | Seated lateral flexion of the trunk against gravity | 3 × 45 s 1×/Day 1 Week | |||
3 | Non-Weight-Bearing | Static |
| 5 × 45 s 1×/Day Progress from 25 to 100% MVIC 1 Week Exercise A 1 Week Exercise B | |
Single-Limb Support |
| ||||
3+ | Single-Limb Support | Static |
| 5 × 45 s 3–4 Days/Week Progress from 25 to 100% MVIC 1 Week Exercise A 1 Week Exercise B | |
| |||||
Strength | 4 | Non-Weight-Bearing | Static |
| 5 × 45 s 3–4 Days/Week Progress from 25 to 100% MVIC 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C |
| |||||
| |||||
5 | Non-Weight-Bearing | Dynamic |
| 3 × 12 3–4 Days/Week 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C | |
| |||||
| |||||
6 | Non-Weight-Bearing | Dynamic |
| 3 × 8 3–4 Days/Week 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C | |
| |||||
| |||||
7 | Non-Weight-Bearing | Dynamic |
| 3 × 8 3–4 Days/Week 1 Week Exercise A 1 Week Exercise B 1 Week Exercise C 1 week Exercise D | |
| |||||
| |||||
|
Level | Goal | Criteria for Progression |
---|---|---|
1 | Low-level activation |
|
2 | Activation as an indirect stabilizing muscle |
|
3/3+ | Direct higher-level activation of the muscle |
|
4 | Beginning of strength phase—open-chain long lever isometric |
|
5 | Transition into isotonic strengthening |
|
6 | Strengthen in closed-chain isotonic table exercises |
|
7 | Incorporate eccentric movement and bilateral movements for higher intensity strengthening |
|
Exercise | Starting Position | Ending Position |
---|---|---|
Sitting with a straight back | ||
Sitting in hyperlordosis | ||
Side-lying traditional clam shell | ||
Side-lying hip abduction | ||
Seated lateral flexion of the trunk against gravity | ||
Seated isometric at 90° of hip flexion | ||
Standing ipsilateral hip flexion isometric at 30° | ||
Standing ipsilateral hip flexion isometric at 60° | ||
Standing ipsilateral hip flexion isometric at 90° | ||
Straight leg isometric at 60° of hip flexion | ||
Straight leg isometric at 30° of hip flexion | ||
Straight leg isometric at 0° of hip flexion | ||
Supine hip flexion | ||
Active straight leg raise | ||
Active straight leg raise with weight | ||
Trunk flexion with bent knees | ||
Hip flexion with straight supported legs | ||
Hip flexion with bent supported legs | ||
Eccentric leg raise | ||
Eccentric leg raise with weight | ||
Bilateral leg lift | ||
Bilateral leg lift with weight |
Appendix C. Risk of Bias Tool
Item | Criteria | Answers |
---|---|---|
Reporting | ||
1 | Is the hypothesis/aim/objective of the study clearly described? | Yes = 1 No = 0 |
2 | Are the main outcomes to be measured clearly described in the Introduction or Methods section? If the main outcomes are first mentioned in the Results section, the question should be answered no. | Yes = 1 No = 0 |
3 | Are the characteristics of the patients included in the study clearly described? In cohort studies and trials, inclusion and/or exclusion criteria should be given. In case–control studies, a case definition and the source for controls should be given. | Yes = 1 No = 0 |
4 | Are the interventions of interest clearly described? Treatments and placebo (where relevant) that are to be compared should be clearly described. | Yes = 1 No = 0 |
5 | Are the distributions of principal confounders in each group of subjects to be compared clearly described? A list of principal confounders is provided. | Yes = 2 Partially = 1 No = 0 |
6 | Are the main findings of the study clearly described? Simple outcome data (including denominators and numerators) should be reported for all major findings so that the reader can check the major analyses and conclusions. (This question does not cover statistical tests that are considered below). | Yes = 1 No = 0 |
7 | Does the study provide estimates of the random variability in the data for the main outcomes? In non-normally distributed data, the interquartile range of results should be reported. In normally distributed data, the standard error, standard deviation or confidence intervals should be reported. If the distribution of the data are not described, it must be assumed that the estimates used were appropriate and the question should be answered “yes”. | Yes = 1 No = 0 |
8 | Have all important adverse events that may be a consequence of the intervention been reported? This should be answered “yes” if the study demonstrates that there was a comprehensive attempt to measure adverse events. (A list of possible adverse events is provided). | Yes = 1 No = 0 |
9 | Have the characteristics of patients lost to follow-up been described? This should be answered “yes” where there were no losses to follow-up or where losses to follow-up were so small that findings would be unaffected by their inclusion. This should be answered “no” where a study does not report the number of patients lost to follow-up. | Yes = 1 No = 0 |
10 | Have actual probability values been reported (e.g., 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001? | Yes = 1 No = 0 |
External validity | ||
11 | Were the subjects asked to participate in the study representative of the entire population from which they were recruited? The study must identify the source population for patients and describe how the patients were selected. Patients would be representative if they comprised the entire source population, an unselected sample of consecutive patients, or a random sample. Random sampling is only feasible where a list of all members of the relevant population exists. Where a study does not report the proportion of the source population from which the patients are derived, the question should be answered as “unable to determine”. | Yes = 1 No = 0 Unable to determine = 0 |
12 | Were those subjects who were prepared to participate representative of the entire population from which they were recruited? The proportion of those asked who agreed should be stated. Validation that the sample was representative would include demonstrating that the distribution of the main confounding factors was the same in the study sample and the source population. | Yes = 1 No = 0 Unable to determine = 0 |
13 | Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? For the question to be answered “yes”, the study should demonstrate that the intervention was representative of that in use in the source population. The question should be answered “no” if, for example, the intervention was undertaken in a specialist center unrepresentative of the hospitals most of the source population would attend. | Yes = 1 No = 0 Unable to determine = 0 |
Internal validity—bias | ||
14 | Was an attempt made to blind study subjects to the intervention they have received? For studies where the patients would have no way of knowing which intervention they received, this should be answered “yes”. | Yes = 1 No = 0 Unable to determine = 0 |
15 | Was an attempt made to blind those measuring the main outcomes of the intervention? | Yes = 1 No = 0 Unable to determine = 0 |
17 | In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case–control studies, is the time period between the intervention and outcome the same for cases and controls? Where follow-up was the same for all study patients, the answer should be “yes”. If different lengths of follow-up were adjusted for by, for example, survival analysis, the answer should be “yes”. Studies where differences in follow-up are ignored should be answered “no”. | Yes = 1 No = 0 Unable to determine = 0 |
18 | Were the statistical tests used to assess the main outcomes appropriate? The statistical techniques used must be appropriate to the data. For example, nonparametric methods should be used for small sample sizes. Where little statistical analysis has been undertaken but where there is no evidence of bias, the question should be answered “yes”. If the distribution of the data (normal or not) is not described, it must be assumed that the estimates used were appropriate and the question should be answered “yes”. | Yes = 1 No = 0 Unable to determine = 0 |
19 | Was compliance with the intervention/s reliable? Where there was noncompliance with the allocated treatment or where there was contamination of one group, the question should be answered “no”. For studies where the effect of any misclassification was likely to bias any association to the null, the question should be answered “yes”. | Yes = 1 No = 0 Unable to determine = 0 |
20 | Were the main outcome measures used accurate (valid and reliable)? For studies where the outcome measures are clearly described, the question should be answered “yes”. For studies which refer to other work or that demonstrates the outcome measures are accurate, the question should be answered as “yes”. | Yes = 1 No = 0 Unable to determine = 0 |
Internal validity—confounding (selection bias) | ||
21 | Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited from the same population? For example, patients for all comparison groups should be selected from the same hospital. The question should be answered “unable to determine” for cohort and case–control studies where there is no information concerning the source of patients included in the study. | Yes = 1 No = 0 Unable to determine = 0 |
22 | Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case–control studies) recruited over the same period of time? For a study that does not specify the time period over which patients were recruited, the question should be answered as “unable to determine”. | Yes = 1 No = 0 Unable to determine = 0 |
23 | Were study subjects randomized to intervention groups? Studies that state that subjects were randomized should be answered “yes” except where the method of randomization would not ensure random allocation. For example, alternate allocation would score “no” because it is predictable. | Yes = 1 No = 0 Unable to determine = 0 |
24 | Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? All nonrandomized studies should be answered “no”. If assignment was concealed from patients but not from staff, it should be answered “no”. | Yes = 1 No = 0 Unable to determine = 0 |
25 | Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? This question should be answered “no” for trials if the main conclusions of the study were based on analyses of treatment rather than intention to treat; the distribution of known confounders in the different treatment groups was not described; or the distribution of known confounders differed between the treatment groups but was not taken into account in the analyses. In non-randomized studies, if the effect of the main confounders was not investigated or confounding was demonstrated but no adjustment was made in the final analyses, the question should be answered as “no”. | Yes = 1 No = 0 Unable to determine = 0 |
26 | Were losses of patients to follow-up taken into account? If the numbers of patients lost to follow-up are not reported, the question should be answered as “unable to determine”. If the proportion lost to follow-up was too small to affect the main findings, the question should be answered “yes”. | Yes = 1 No = 0 Unable to determine = 0 |
Power | ||
27 | Was a power analysis performed? | Yes = 1 No = 0 Unable to determine = 0 |
Appendix D. Electrode Type
First Author/Year | Fine-Wire Electrode | Surface Electrode |
---|---|---|
Andersson et al., 1997 [26] | Fine-Wire Iiliacus Bandpass Filter 10–1000 Hz | |
Okubo et al., 2021 [29] | Fine-Wire Psoas Major | |
Yamane et al., 2019 [30] | Fine-wire Psoas Major and Iliacus | |
Kim et al., 2016 [31] | Surface sensor iliopsoas | |
Sugajima et al., 1996 [34] | Fine-Wire Iliopsoas | |
Hu et al., 2011 [27] | Fine-Wire Iliopsoas Bandpass Filter Between 20 Hz and 1 kHz | |
Andersson et al., 1995 [32] | Fine-Wire Psoas Major and Iliacus | |
Philippon et al., 2011 [33] | Fine-Wire Iliopsoas | |
Jiroumaru et al., 2014 [28] | Active electrode iliacus |
Appendix E
Exercise | Average %MVIC Activation of Iliacus |
---|---|
Bilateral leg lift | 86 |
Hip flexion bent supported legs | 80 |
Unilateral leg lift | 68 |
Straight leg raise isometric @60° with 20° ER and 30° ABD | 65.2 |
Hip flexion straight supported legs | 60 |
Straight leg raise isometric @60° with 30° ABD | 59 |
Straight leg raise isometric @45° with 30° ABD | 48.9 |
Straight leg raise isometric @60° with 20° ER | 47.6 |
Straight leg raise isometric @45° with 20° ER and 30° ABD | 46.7 |
Straight leg raise isometric @60° | 44.1 |
Straight leg raise isometric @45° with 20° ER | 41.2 |
Straight leg raise isometric @45° | 40.6 |
Straight leg raise isometric @30° | 38.4 |
Straight leg raise isometric @30° with 20° ER and 30° ABD | 36.7 |
Straight leg raise isometric @30° with 20° ER | 35 |
Straight leg raise isometric @30° with 30° ABD | 32.5 |
Incomplete bent unsupported leg task | 29 |
Trunk flexion bent legs | 16.5 |
Exercise | Average %MVIC of Psoas Major |
---|---|
Straight leg raise isometric @60° with 20° ER and 30° ABD | 67.1 |
Straight leg raise isometric @60° | 60.8 |
Straight leg raise isometric @60° with 20° ER | 60.8 |
Straight leg raise isometric @60° with 30° ABD | 54.3 |
Straight leg raise isometric @45° with 20° ER and 30° ABD | 50.3 |
Straight leg raise isometric @45° | 48.8 |
Straight leg raise isometric @45° with 30° ABD | 45.6 |
Straight leg raise isometric @30° with 20° ER | 44.5 |
Straight leg raise isometric @30° with 20° ER and 30° ABD | 41.1 |
Straight leg raise isometric @45° with 20° ER | 37.7 |
Straight leg raise isometric @30° with 30° ABD | 35.9 |
Hold at top straight leg raise | 35 |
Straight leg raise isometric @30° | 34 |
Late concentric straight leg raise | 30 |
Mid concentric straight leg raise | 15 |
Mid eccentric straight leg raise | 15 |
Early concentric straight leg raise | 10 |
Late eccentric straight leg raise | 10 |
Exercise | Average %MVIC Iliopsoas |
---|---|
Eccentric leg raise | 23.6 |
Straight leg raise | 17.6 |
Eccentric sit up | 15.8 |
Sit up | 13.2 |
Exercise | Average EMG Amplitude (µV) of Iliacus |
---|---|
One leg standing and other flexed at the hip ipsilateral @90° | 99 |
One leg standing and other flexed at the hip ipsilateral@60° | 75 |
Static leg lift at 60° ipsilateral | 59 |
Maximal straight leg abduction ipsilateral | 56 |
One leg standing one leg flexed to 90 at the hip and knee ipsilateral | 55 |
Static leg lift at 60° bilateral | 55 |
ASLR ipsilateral with weight | 50 |
One leg standing and other flexed at the hip ipsilateral @30° | 43 |
60° static angle with support and straight legs | 42 |
ASLR ipsilateral | 40 |
Extension max contralateral | 26 |
Hyperlordosis seated | 22 |
Extension 30° contralateral | 16 |
Maximal straight leg abduction contralateral | 16 |
Static lateral flexion to the contralateral side | 16 |
Static lateral flexion to the ipsilateral side against gravity | 16 |
Sitting with a straight back | 4 |
One leg standing and other flexed at the hip contralateral @30° | 1 |
ASLR contralateral | 0 |
ASLR contralateral with weight | 0 |
Standing | 0 |
Standing with trunk flexed 30° at the hip | 0 |
One leg standing and other flexed at the hip ipsilateral @0° | 0 |
One leg standing and other flexed at the hip contralateral @0° | 0 |
One leg standing and other flexed at the hip contralateral @60° | 0 |
One leg standing and other flexed at the hip contralateral @90° | 0 |
One leg standing one leg flexed to 90 at the hip and knee contralateral | 0 |
Extension 30° ipsilateral | 0 |
Extension max ipsilateral | 0 |
Static lateral flexion to the ipsilateral side | 0 |
Exercise | Average EMG Amplitude (µV) of Psoas Major |
---|---|
One leg standing and other flexed at the hip ipsilateral @90° | 85 |
Static leg lift at 60° bilateral | 59 |
Static leg lift at 60° ipsilateral | 58 |
Static lateral flexion to the ipsilateral side against gravity | 54 |
One leg standing and other flexed at the hip ipsilateral @60° | 52 |
60° static angle with support and straight legs | 52 |
Maximal straight leg abduction ipsilateral | 36 |
One leg standing one leg flexed to 90 at the hip and knee ipsilateral | 34 |
One leg standing and other flexed at the hip ipsilateral @30° | 21 |
Hyperlordosis seated | 17 |
Static lateral flexion to the contralateral side | 16 |
ASLR contralateral with weight | 10 |
ASLR ipsilateral with weight | 10 |
Sitting with a straight back | 9 |
ASLR contralateral | 6 |
ASLR ipsilateral | 6 |
Extension 30° contralateral | 4 |
Extension max contralateral | 4 |
Maximal straight leg abduction contralateral | 4 |
One leg standing and other flexed at the hip contralateral @90° | 3 |
Extension max ipsilateral | 2 |
One leg standing and other flexed at the hip contralateral @30° | 1 |
One leg standing and other flexed at the hip contralateral @60° | 1 |
Standing | 0 |
Standing with trunk flexed 30° at the hip | 0 |
One leg standing and other flexed at the hip ipsilateral @0° | 0 |
One leg standing and other flexed at the hip contralateral @0° | 0 |
One leg standing one leg flexed to 90 at the hip and knee contralateral | 0 |
Extension 30° ipsilateral | 0 |
Static lateral flexion to the ipsilateral side | 0 |
Exercise | Average EMG Amplitude (µV) of Iliopsoas |
---|---|
60% MVC with immersion | 514 |
40% MVC with immersion | 334 |
60% MVC without immersion | 252 |
40% MVC without immersion | 215 |
20% MVC with immersion | 209 |
20% MVC without immersion | 185 |
Supine hip flexion concentric | 17.5 |
Sidelying hip abduction-ER concentric | 16 |
Supine hip flexion eccentric | 14.6 |
Traditional hip clam concentric | 11.9 |
Sidelying hip abduction-ER eccentric | 11.1 |
Traditional hip clam eccentric | 8 |
Sidelying hip abduction-wall concentric | 7.8 |
Hip clam-neutral concentric | 7.8 |
Sidelying hip abduction-wall eccentric | 6.3 |
Hip clam-neutral eccentric | 4.8 |
Resisted hip extension concentric | 4.4 |
Resisted knee flexion concentric | 4.1 |
Resisted hip extension eccentric | 3.9 |
Resisted knee extension concentric | 3.8 |
Resisted knee flexion eccentric | 3.7 |
Sidelying hip abduction concentric | 3.6 |
Stool hip rotations eccentric | 3.5 |
Resisted knee extension concentric | 3.5 |
Stool hip rotations concentric | 3.4 |
Sidelying hip abduction eccentric | 3.3 |
Double-leg bridge concentric | 3 |
Double-leg bridge eccentric | 2.7 |
Single leg bridge concentric | 2.5 |
Prone heel squeeze concentric | 2.3 |
Single leg bridge eccentric | 2.1 |
Exercise | RMS Value of Iliopsoas |
---|---|
Hip flexion angle @30° | 1.1 |
Hip flexion angle @60° | 1.05 |
Hip flexion angle @0° | 1 |
Hip flexion angle @-10° | 0.9 |
References
- Lifshitz, L.; Bar Sela, S.; Gal, N.; Martin, R.; Fleitman Klar, M. Iliopsoas the Hidden Muscle: Anatomy, Diagnosis, and Treatment. Curr. Sports Med. Rep. 2020, 19, 235–243. [Google Scholar] [CrossRef] [PubMed]
- Tramer, J.S.; Holmich, P.; Safran, M.R. The Iliopsoas: Anatomy, Clinical Evaluation, and Its Role in Hip Pain in the Athlete: A Scoping Review. J. Am. Acad. Orthop. Surg. 2024, 32, e620–e630. [Google Scholar] [CrossRef] [PubMed]
- Retchford, T.H.; Crossley, K.M.; Grimaldi, A.; Kemp, J.L.; Cowan, S.M. Can Local Muscles Augment Stability in the Hip? A Narrative Literature Review. J. Musculoskelet. Neuronal Interact. 2013, 13, 1–12. [Google Scholar] [PubMed]
- Leide, R.; Bohman, A.; Wenger, D.; Overgaard, S.; Tiderius, C.J.; Rogmark, C. Hip Dysplasia Is Not Uncommon but Frequently Overlooked: A Cross-Sectional Study Based on Radiographic Examination of 1870 Adults. Acta Orthop. 2021, 92, 575–580. [Google Scholar] [CrossRef]
- Dangin, A.; Tardy, N.; Wettstein, M.; May, O.; Bonin, N. Microinstability of the Hip: A Review. Orthop. Traumatol. Surg. Res. 2016, 102 (Suppl. S8), S301–S309. [Google Scholar] [CrossRef]
- Ejnisman, L.; Elisman, K.; Safran, M.R. Effectiveness of Nonoperative Management of Hip Microinstability. Am. J. Sports Med. 2022, 50, 1013–1019. [Google Scholar] [CrossRef]
- Bsat, S.; Frei, H.; Beaulé, P.E. The Acetabular Labrum: A Review of Its Function. Bone Jt. J. 2016, 98-B, 730–735. [Google Scholar] [CrossRef]
- Bolia, I.; Chahla, J.; Locks, R.; Briggs, K.; Philippon, M.J. Microinstability of the Hip: A Previously Unrecognized Pathology. Muscles Ligaments Tendons J. 2016, 6, 354–360. [Google Scholar] [CrossRef]
- Dorel, S.; Guilhem, G.; Couturier, A.; Hug, F. Adjustment of Muscle Coordination during an All-out Sprint Cycling Task. Med. Sci. Sports Exerc. 2012, 44, 2154–2164. [Google Scholar] [CrossRef]
- Lenhart, R.L.; Francis, C.A.; Lenz, A.L.; Thelen, D.G. Empirical Evaluation of Gastrocnemius and Soleus Function during Walking. J. Biomech. 2014, 47, 2969–2974. [Google Scholar] [CrossRef]
- Howell, M.; Rae, F.J.; Khan, A.; Holt, G. Iliopsoas Pathology after Total Hip Arthroplasty: A Young Person’s Complication. Bone Jt. J. 2021, 103-B, 305–308. [Google Scholar] [CrossRef] [PubMed]
- Verhaegen, J.C.F.; Vandeputte, F.-J.; Van den Broecke, R.; Roose, S.; Driesen, R.; Timmermans, A.; Corten, K. Risk Factors for Iliopsoas Tendinopathy After Anterior Approach Total Hip Arthroplasty. J. Arthroplast. 2023, 38, 511–518. [Google Scholar] [CrossRef] [PubMed]
- Weintraub, M.T.; Barrack, T.N.; Burnett, R.A.; Serino, J.; Bhanot, S.S.; Della Valle, C.J. Ultrasound-Guided Iliopsoas Bursal Injections for Management of Iliopsoas Bursitis After Total Hip Arthroplasty. J. Arthroplast. 2023, 38 (Suppl. S2), S426–S430. [Google Scholar] [CrossRef] [PubMed]
- Muaidi, Q.I. Rehabilitation of Patellar Tendinopathy. J. Musculoskelet. Neuronal Interact. 2020, 20, 535–540. [Google Scholar]
- Silbernagel, K.G.; Hanlon, S.; Sprague, A. Current Clinical Concepts: Conservative Management of Achilles Tendinopathy. J. Athl. Train. 2020, 55, 438–447. [Google Scholar] [CrossRef]
- Rauseo, C. The Rehabilitation of a Runner with Iliopsoas Tendinopathy Using an Eccentric-Biased Exercise—A Case Report. Int. J. Sports Phys. Ther. 2017, 12, 1150–1162. [Google Scholar] [CrossRef]
- Yamanaka, R.; Wakasawa, S.; Yamashiro, K.; Kodama, N.; Sato, D. Effect of Resistance Training of Psoas Major in Combination with Regular Running Training on Performance in Long-Distance Runners. Int. J. Sports Physiol. Perform. 2021, 16, 906–909. [Google Scholar] [CrossRef]
- Young, W.B.; Rath, D.A. Enhancing Foot Velocity in Football Kicking: The Role of Strength Training. J. Strength. Cond. Res. 2011, 25, 561–566. [Google Scholar] [CrossRef]
- Mendis, M.D.; Wilson, S.J.; Stanton, W.; Hides, J.A. Validity of Real-Time Ultrasound Imaging to Measure Anterior Hip Muscle Size: A Comparison with Magnetic Resonance Imaging. J. Orthop. Sports Phys. Ther. 2010, 40, 577–581. [Google Scholar] [CrossRef]
- Judd, D.L.; Thomas, A.C.; Dayton, M.R.; Stevens-Lapsley, J.E. Strength and Functional Deficits in Individuals with Hip Osteoarthritis Compared to Healthy, Older Adults. Disabil. Rehabil. 2014, 36, 307–312. [Google Scholar] [CrossRef]
- Ebert, J.R.; Edwards, P.K.; Fick, D.P.; Janes, G.C. A Systematic Review of Rehabilitation Exercises to Progressively Load the Gluteus Medius. J. Sport. Rehabil. 2017, 26, 418–436. [Google Scholar] [CrossRef] [PubMed]
- Moore, D.; Semciw, A.I.; Pizzari, T. A Systematic Review and Meta-Analysis of Common Therapeutic Exercises That Generate Highest Muscle Activity in the Gluteus Medius and Gluteus Minimus Segments. Int. J. Sports Phys. Ther. 2020, 15, 856–881. [Google Scholar] [CrossRef] [PubMed]
- Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009, 6, e1000097. [Google Scholar] [CrossRef] [PubMed]
- Swartz, M.K. The PRISMA statement: A guideline for systematic reviews and meta-analyses. J. Pediatr. Health Care Off. Publ. Natl. Assoc. Pediatr. Nurse Assoc. Pract. 2011, 25, 1–2. [Google Scholar] [CrossRef]
- Cumpston, M.; Li, T.; Page, M.J.; Chandler, J.; Welch, V.A.; Higgins, J.P.; Thomas, J. Updated guidance for trusted systematic reviews: A new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Database Syst. Rev. 2019, 10, ED000142. [Google Scholar] [CrossRef]
- Andersson, E.A.; Nilsson, J.; Ma, Z.; Thorstensson, A. Abdominal and Hip Flexor Muscle Activation during Various Training Exercises. Eur. J. Appl. Physiol. Occup. Physiol. 1997, 75, 115–123. [Google Scholar] [CrossRef]
- Hu, H.; Meijer, O.G.; van Dieën, J.H.; Hodges, P.W.; Bruijn, S.M.; Strijers, R.L.; Nanayakkara, P.W.B.; van Royen, B.J.; Wu, W.H.; Xia, C. Is the Psoas a Hip Flexor in the Active Straight Leg Raise? Eur. Spine J. 2011, 20, 759–765. [Google Scholar] [CrossRef]
- Jiroumaru, T.; Kurihara, T.; Isaka, T. Measurement of Muscle Length-Related Electromyography Activity of the Hip Flexor Muscles to Determine Individual Muscle Contributions to the Hip Flexion Torque. Springerplus 2014, 3, 624. [Google Scholar] [CrossRef]
- Okubo, Y.; Kaneoka, K.; Hasebe, K.; Matsunaga, N.; Imai, A.; Hodges, P.W. Differential activation of psoas major and rectus femoris during active straight leg raise to end range. J. Electromyogr. Kinesiol. Off. J. Int. Soc. Electrophysiol. Kinesiol. 2021, 60, 102588. [Google Scholar] [CrossRef]
- Yamane, M.; Aoki, M.; Sasaki, Y.; Kawaji, H. Understanding the Muscle Activity Pattern of the Hip Flexors during Straight Leg Raising in Healthy Subjects. Prog. Rehabil. Med. 2019, 4, 20190007. [Google Scholar] [CrossRef]
- Kim, K.; Lee, T. Comparison of Muscular Activities in the Abdomen and Lower Limbs While Performing Sit-up and Leg-Raise. J. Phys. Ther. Sci. 2016, 28, 491–494. [Google Scholar] [CrossRef] [PubMed]
- Andersson, E.; Oddsson, L.; Grundström, H.; Thorstensson, A. The Role of the Psoas and Iliacus Muscles for Stability and Movement of the Lumbar Spine, Pelvis and Hip. Scand. J. Med. Sci. Sports 1995, 5, 10–16. [Google Scholar] [CrossRef] [PubMed]
- Philippon, M.J.; Decker, M.J.; Giphart, J.E.; Torry, M.R.; Wahoff, M.S.; LaPrade, R.F. Rehabilitation Exercise Progression for the Gluteus Medius Muscle with Consideration for Iliopsoas Tendinitis: An in Vivo Electromyography Study. Am. J. Sports Med. 2011, 39, 1777–1785. [Google Scholar] [CrossRef] [PubMed]
- Sugajima, Y.; Mitarai, G.; Koeda, M.; Moritani, T. Characteristic Changes of Motor Unit Activity in Hip Joint Flexor Muscles during Voluntary Isometric Contraction during Water Immersion. J. Electromyogr. Kinesiol. 1996, 6, 83–95. [Google Scholar] [CrossRef] [PubMed]
- Armijo-Olivo, S.; Fuentes, J.; da Costa, B.R.; Saltaji, H.; Ha, C.; Cummings, G.G. Blinding in Physical Therapy Trials and Its Association with Treatment Effects: A Meta-epidemiological Study. Am. J. Phys. Med. Rehabil. 2017, 96, 34–44. [Google Scholar] [CrossRef]
- Zhu, Z.; Zhang, J.; Sheng, J.; Zhang, C.; Xie, Z. Low Back Pain Caused by Iliopsoas Tendinopathy Treated with Ultrasound-Guided Local Injection of Anesthetic and Steroid: A Retrospective Study. J. Pain Res. 2020, 13, 3023–3029. [Google Scholar] [CrossRef]
- Yen, Y.-M.; Lewis, C.L.; Kim, Y.-J. Understanding and Treating the Snapping Hip. Sports Med. Arthrosc. Rev. 2015, 23, 194–199. [Google Scholar] [CrossRef]
- Mank, V.M.; Barranco-Trabi, J.; Mank, J.K.; Roberts, J.; Newman, D.P. A Case Study of Chronic Iliopsoas Tendinopathy and Sacroiliac Joint Dysfunction Masquerading As Pelvic Girdle Pain. Cureus 2021, 13, e15719. [Google Scholar] [CrossRef]
- Stewart, C.; King, M.G.; Kemp, J.L.; Mentiplay, B.F.; O’Brien, M.J.; Perraton, Z.; Lawrenson, P.R.; Semciw, A.I. Hip Muscle Activity in People with Hip-Related Pain Compared to Asymptomatic Controls: A Systematic Review. J. Electromyogr. Kinesiol. 2023, 71, 102784. [Google Scholar] [CrossRef]
- Konrad, A.; Močnik, R.; Titze, S.; Nakamura, M.; Tilp, M. The Influence of Stretching the Hip Flexor Muscles on Performance Parameters. A Systematic Review with Meta-Analysis. Int. J. Environ. Res. Public Health 2021, 18, 1936. [Google Scholar] [CrossRef]
- Deluca, C. The Use of Surface Electromyography in Biomechanics. J. Appl. Biomech. 1997, 13, 135–163. [Google Scholar] [CrossRef]
Question Component | Inclusion Criteria | Exclusion Criteria |
---|---|---|
Population | Healthy (no comorbidities, no history of low back/hip pain) | Non-human study, cadaver study, pathological population |
Intervention | E EMG study of the hip flexors | No EMG measurement of iliopsoas specifically |
Comparison | • n/a | • n/a |
Outcome | • n/a | • n/a |
Study Design | • any | • any |
Time | • any | • any |
First Author (Year) | Study Type | Research Question(s)/Hypotheses | Patient Population Specifics | Methodology | Conclusions |
---|---|---|---|---|---|
Andersson, 1997 [26] | Cross- sectional study |
|
| Measurement tool:
|
|
Hu, 2011 [27] | Non-randomized crossover trial |
|
| Measurement tool:
|
|
Jiroumaru, 2014 [28] | Cross-sectional study |
|
| Measurement tool:
|
|
Okubo, 2021 [29] | Cross-sectional study | What is the activation of the hip flexor and abdominal muscles during an ASLR to end-range hip flexion? |
| Measurement tool:
|
|
Yamane, 2019 [30] | Cross-sectional study |
|
| Measurement tool:
|
|
Kim, 2016 [31] | Cross-sectional study |
|
| Measurement tool:
|
|
Andersson, 1995 [32] | Cross-Sectional study |
|
| Measurement tool:
|
|
Philippon, 2011 [33] | Descriptive laboratory study |
|
| Measurement tool:
|
|
Sugajima, 1996 [34] | Non-randomized crossover trial |
|
| Measurement tool:
|
|
Downs and Black Criteria | Andersson 1997 [26] | Andersson 1995 [32] | Hu 2011 [27] | Jiroumaru 2014 [28] | Kim 2016 [31] | Okubo 2021 [29] | Philippon 2011 [33] | Sugajima 1996 [34] | Yamane 2019 [30] |
---|---|---|---|---|---|---|---|---|---|
1 | |||||||||
2 | |||||||||
3 | |||||||||
4 | |||||||||
5 | |||||||||
6 | |||||||||
7 | |||||||||
8 | |||||||||
9 | |||||||||
10 | |||||||||
11 | |||||||||
12 | |||||||||
13 | |||||||||
14 | |||||||||
15 | |||||||||
16 | |||||||||
17 | |||||||||
18 | |||||||||
19 | |||||||||
20 | |||||||||
21 | |||||||||
22 | |||||||||
23 | |||||||||
24 | |||||||||
25 | |||||||||
26 | |||||||||
27 | |||||||||
* Total | 13 | 15 | 15 | 13 | 13 | 13 | 14 | 15 | 15 |
First Author (Year) | Methodology | Strengths and Limitations | Interpretation of Analysis |
---|---|---|---|
Andersson (1995) [32] |
| Limitations:
| Clinically applicable |
Andersson (1997) [26] |
| Limitations:
| Caution with clinical application |
Hu (2011) [27] |
| Limitations:
| Clinically applicable |
Jiroumaru (2014) [28] |
| Limitations: Conclusions within paper cannot be substantiated by the methods used | Limited clinical applicability |
Kim (2016) [31] |
| Limitations:
| Caution with clinical application |
Okubo (2021) [29] |
| Limitations:
| Surface EMG data: limited clinical applicability Intramuscular EMG data: clinically applicable |
Philippon (2011) [33] |
| Strengths:
| Clinically applicable |
Sugajima (1996) [34] |
| Limitations:
| Caution with clinical application |
Yamane (2019) [30] |
| Limitations:
| Limited clinical applicability due to unvalidated assumptions that were used to create the conclusion |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Juan, J.; Leff, G.; Kevorken, K.; Jeanfavre, M. Hip Flexor Muscle Activation During Common Rehabilitation and Strength Exercises. J. Clin. Med. 2024, 13, 6617. https://doi.org/10.3390/jcm13216617
Juan J, Leff G, Kevorken K, Jeanfavre M. Hip Flexor Muscle Activation During Common Rehabilitation and Strength Exercises. Journal of Clinical Medicine. 2024; 13(21):6617. https://doi.org/10.3390/jcm13216617
Chicago/Turabian StyleJuan, Jessica, Gretchen Leff, Kate Kevorken, and Michael Jeanfavre. 2024. "Hip Flexor Muscle Activation During Common Rehabilitation and Strength Exercises" Journal of Clinical Medicine 13, no. 21: 6617. https://doi.org/10.3390/jcm13216617
APA StyleJuan, J., Leff, G., Kevorken, K., & Jeanfavre, M. (2024). Hip Flexor Muscle Activation During Common Rehabilitation and Strength Exercises. Journal of Clinical Medicine, 13(21), 6617. https://doi.org/10.3390/jcm13216617